Eukaryotic Translation Initiation Factor 2D (EIF2D) Peptide
EIF2D
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all EIF2D products
- EIF2D (Eukaryotic Translation Initiation Factor 2D (EIF2D))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KVTVVRNLEA YGLDPYSVAA ILQQRCQAST TVNPAPGAKD SLQVQIQGNQ
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LGTN antibody,
Alternative Names: Ligatin control peptide, Ligatin antibody Blocking Peptide, Anti-Ligatin Blocking Peptide, HCA56 Blocking Peptide, LGTN Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- EIF2D (Eukaryotic Translation Initiation Factor 2D (EIF2D))
- Synonyms
- LGTN Peptide, HCA56 Peptide, D1Ertd5e Peptide, Lgtn Peptide, eukaryotic translation initiation factor 2D Peptide, EIF2D Peptide, Eif2d Peptide
- Background
- LGTN is a protein receptor that localizes phosphoglycoproteins within endosomes and at the cell periphery. This trafficking receptor for phosphoglycoproteins may play a role in neuroplasticity by modulating cell-cell interactions, intracellular adhesion, and protein binding at membrane surfaces. In hippocampal neurons, long-lasting down-regulation of ligatin mRNA levels occurs via post-transcriptional RNA processing following glutamate receptor activation. This protein contains single PUA and SUI1 domains and these domains may function in RNA binding and translation initiation, respectively.
- Molecular Weight
- 65 kDa
-
You are here:
